<table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl3" position="float"><object-id pub-id-type="doi">10.7554/eLife.00969.012</object-id><label>Table 3.</label><caption><p>Quantitative competitive binding assays reveal additional kinase targets of vemurafenib</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.00969.012">http://dx.doi.org/10.7554/eLife.00969.012</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th/><th>Percent control (50 nM)</th><th>Percent control (200 nM)</th><th>Percent control (1000 nM)</th><th>Percent control (10 &#956;M)</th><th>Calculated estimate of IC50 (nM)</th><th>Published biochemical IC50 (nM)</th></tr></thead><tbody><tr><td>ASK1</td><td>MAP3K5</td><td align="char" char=".">90</td><td align="char" char=".">94</td><td align="char" char=".">97</td><td align="char" char=".">100</td><td align="char" char=".">11,972.22</td><td>&gt;1000</td></tr><tr><td>ASK2</td><td>MAP3K6</td><td align="char" char=".">94</td><td align="char" char=".">98</td><td align="char" char=".">100</td><td align="char" char=".">74</td><td/><td/></tr><tr><td>BLK</td><td>BLK</td><td align="char" char=".">96</td><td align="char" char=".">66</td><td align="char" char=".">30</td><td align="char" char=".">0.55</td><td align="char" char=".">518.03</td><td>547</td></tr><tr><td><bold>BRAF(V600E)</bold></td><td><bold>BRAF</bold></td><td align="char" char="."><bold>63</bold></td><td align="char" char="."><bold>25</bold></td><td align="char" char="."><bold>5.4</bold></td><td align="char" char="."><bold>0.5</bold></td><td align="char" char="."><bold>64.78</bold></td><td><bold>31</bold></td></tr><tr><td>BRK</td><td>PTK6</td><td align="char" char=".">63</td><td align="char" char=".">28</td><td align="char" char=".">6.9</td><td align="char" char=".">0.35</td><td align="char" char=".">68.04</td><td>213</td></tr><tr><td>DLK</td><td>MAP3K12</td><td align="char" char=".">98</td><td align="char" char=".">97</td><td align="char" char=".">66</td><td align="char" char=".">92</td><td/><td/></tr><tr><td>FGR</td><td>FGR</td><td align="char" char=".">65</td><td align="char" char=".">49</td><td align="char" char=".">13</td><td align="char" char=".">1.6</td><td align="char" char=".">149.26</td><td>63</td></tr><tr><td>HPK1</td><td>MAP4K1</td><td align="char" char=".">95</td><td align="char" char=".">88</td><td align="char" char=".">67</td><td align="char" char=".">15</td><td/><td/></tr><tr><td>LZK</td><td>MAP3K13</td><td align="char" char=".">100</td><td align="char" char=".">99</td><td align="char" char=".">93</td><td align="char" char=".">74</td><td/><td/></tr><tr><td>MAP3K1</td><td>MAP3K1</td><td align="char" char=".">98</td><td align="char" char=".">84</td><td align="char" char=".">89</td><td align="char" char=".">81</td><td/><td/></tr><tr><td>MAP3K15</td><td>MAP3K15</td><td align="char" char=".">84</td><td align="char" char=".">100</td><td align="char" char=".">84</td><td align="char" char=".">91</td><td/><td/></tr><tr><td>MAP3K2</td><td>MAP3K2</td><td align="char" char=".">91</td><td align="char" char=".">91</td><td align="char" char=".">89</td><td align="char" char=".">83</td><td/><td/></tr><tr><td>MAP3K3</td><td>MAP3K3</td><td align="char" char=".">87</td><td align="char" char=".">97</td><td align="char" char=".">100</td><td align="char" char=".">94</td><td/><td/></tr><tr><td>MAP3K4</td><td>MAP3K4</td><td align="char" char=".">95</td><td align="char" char=".">92</td><td align="char" char=".">87</td><td align="char" char=".">46</td><td/><td/></tr><tr><td>MAP4K2</td><td>MAP4K2</td><td align="char" char=".">99</td><td align="char" char=".">82</td><td align="char" char=".">95</td><td align="char" char=".">46</td><td/><td/></tr><tr><td>MAP4K3</td><td>MAP4K3</td><td align="char" char=".">80</td><td align="char" char=".">90</td><td align="char" char=".">82</td><td align="char" char=".">24</td><td/><td/></tr><tr><td>MAP4K4</td><td>MAP4K4</td><td align="char" char=".">96</td><td align="char" char=".">92</td><td align="char" char=".">83</td><td align="char" char=".">23</td><td align="char" char=".">2842.34</td><td>&gt;1000</td></tr><tr><td><bold>MAP4K5</bold></td><td><bold>MAP4K5</bold></td><td align="char" char="."><bold>62</bold></td><td align="char" char="."><bold>33</bold></td><td align="char" char="."><bold>4.1</bold></td><td align="char" char="."><bold>0.1</bold></td><td align="char" char="."><bold>58.21</bold></td><td><bold>51</bold></td></tr><tr><td>MEK3</td><td>MAP2K3</td><td align="char" char=".">100</td><td align="char" char=".">96</td><td align="char" char=".">98</td><td align="char" char=".">54</td><td/><td/></tr><tr><td><bold>MEK4</bold></td><td><bold>MAP2K4</bold></td><td align="char" char="."><bold>19</bold></td><td align="char" char="."><bold>4.1</bold></td><td align="char" char="."><bold>0.2</bold></td><td align="char" char="."><bold>0.05</bold></td><td align="char" char="."><bold>6.82</bold></td><td/></tr><tr><td>MEK6</td><td>MAP2K6</td><td align="char" char=".">91</td><td align="char" char=".">97</td><td align="char" char=".">87</td><td align="char" char=".">21</td><td align="char" char=".">4080.69</td><td>&gt;1000</td></tr><tr><td>MINK</td><td>MINK1</td><td align="char" char=".">100</td><td align="char" char=".">100</td><td align="char" char=".">91</td><td align="char" char=".">66</td><td align="char" char=".">14,761.44</td><td>&gt;1000</td></tr><tr><td>MKK7</td><td>MAP2K7</td><td align="char" char=".">97</td><td align="char" char=".">95</td><td align="char" char=".">94</td><td align="char" char=".">85</td><td/><td/></tr><tr><td>MLK1</td><td>MAP3K9</td><td align="char" char=".">100</td><td align="char" char=".">93</td><td align="char" char=".">97</td><td align="char" char=".">41</td><td align="char" char=".">13,979.88</td><td>&gt;1000</td></tr><tr><td>MLK2</td><td>MAP3K10</td><td align="char" char=".">92</td><td align="char" char=".">96</td><td align="char" char=".">87</td><td align="char" char=".">78</td><td/><td/></tr><tr><td>MLK3</td><td>MAP3K11</td><td align="char" char=".">98</td><td align="char" char=".">100</td><td align="char" char=".">100</td><td align="char" char=".">77</td><td/><td/></tr><tr><td>MST1</td><td>STK4</td><td align="char" char=".">99</td><td align="char" char=".">83</td><td align="char" char=".">51</td><td align="char" char=".">12</td><td/><td/></tr><tr><td>OSR1</td><td>OXSR1</td><td align="char" char=".">100</td><td align="char" char=".">100</td><td align="char" char=".">89</td><td align="char" char=".">98</td><td/><td/></tr><tr><td>PAK1</td><td>PAK1</td><td align="char" char=".">99</td><td align="char" char=".">98</td><td align="char" char=".">91</td><td align="char" char=".">46</td><td/><td/></tr><tr><td>RIPK1</td><td>RIPK1</td><td align="char" char=".">92</td><td align="char" char=".">100</td><td align="char" char=".">99</td><td align="char" char=".">73</td><td/><td/></tr><tr><td>SRMS</td><td>SRMS</td><td align="char" char=".">24</td><td align="char" char=".">9.6</td><td align="char" char=".">0.75</td><td align="char" char=".">0</td><td align="char" char=".">11.15</td><td>18</td></tr><tr><td>STK39</td><td>STK39</td><td align="char" char=".">100</td><td align="char" char=".">100</td><td align="char" char=".">97</td><td align="char" char=".">66</td><td/><td/></tr><tr><td>TAK1</td><td>MAP3K7</td><td align="char" char=".">93</td><td align="char" char=".">88</td><td align="char" char=".">86</td><td align="char" char=".">88</td><td/><td/></tr><tr><td>TAOK1</td><td>TAOK1</td><td align="char" char=".">91</td><td align="char" char=".">100</td><td align="char" char=".">97</td><td align="char" char=".">79</td><td/><td/></tr><tr><td>TAOK2</td><td>TAOK2</td><td align="char" char=".">98</td><td align="char" char=".">92</td><td align="char" char=".">95</td><td align="char" char=".">70</td><td align="char" char=".">11,770.83</td><td>&gt;1000</td></tr><tr><td>TAOK3</td><td>TAOK3</td><td align="char" char=".">92</td><td align="char" char=".">98</td><td align="char" char=".">92</td><td align="char" char=".">80</td><td align="char" char=".">15,468.75</td><td>&gt;1000</td></tr><tr><td>TNIK</td><td>TNIK</td><td align="char" char=".">95</td><td align="char" char=".">94</td><td align="char" char=".">66</td><td align="char" char=".">11</td><td/><td/></tr><tr><td><bold>ZAK</bold></td><td><bold>ZAK</bold></td><td align="char" char="."><bold>9</bold></td><td align="char" char="."><bold>1.8</bold></td><td align="char" char="."><bold>0.25</bold></td><td align="char" char="."><bold>0.05</bold></td><td align="char" char="."><bold>4.03</bold></td><td/></tr></tbody></table><table-wrap-foot><fn><p>Quantitative competitive binding assays were performed for a group of kinases previously tested against vemurafenib as well as a group of MAP kinases upstream of JNK. Published biochemical IC50s for vemurafenib are listed (see main text) for comparison and demonstrate good quantitative correspondence between estimated <italic>K</italic><sub><italic>d</italic></sub> from binding assays and biochemical IC50s. ZAK and MKK4 (MAP2K4) were very tightly bound by vemurafenib with estimated <italic>K</italic><sub><italic>d</italic></sub> below 50 nM. Bold text indicates the kinases tested for inhibition by vemurafenib with in-vitro kinase assays.</p></fn></table-wrap-foot></table-wrap>